This news is delayed by 15 minutes, sign up now to get live news & full features.
GILD GILEAD SCIENCES INC
+ add to watchlist
$154.98
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Mkt Cap: $192.3B
52 Week High: $157.29
P/E: 93.40
52 Week Low: $93.37
Dividend: $0.04
Shares Outstanding: 1.24B